他拉唑帕利(BMN-673)是是一种高效的口服的多核苷酸ADP-核糖聚合酶（PARP1/2）抑制剂，Ki 值分别为 1.2 nM 和 0.87 nM,用于治疗乳腺癌BRCA突变的晚期乳腺癌患者。
6-Fluoro-4-nitroisobenzofuran-1(3H)-one
4-Fluorobenzaldehyde
4-Amino-6-fluoroisobenzofuran-1(3H)-one
1-Methyl-1,2,4-triazole
1-Methyl-1H-1,2,4-triazole-5-carbaldehyde
(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one 4-methylbenzenesulfonate
Methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate
5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one
(Z)-6-Fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one
Methyl (2S,3S)-7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate
